Completing data — refresh the page later to see the latest
166196-11-8O=C(O)c1cn(Cc2c(F)cccc2F)nn1OPJHWTKDQYKYHL-UHFFFAOYSA-Nmetabolite of CGP-33101
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Not Classified
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Not Classified
Acute Tox. 4 (100%)
Uses4-Descarboxamido Rufanamide 4-Carboxylic Acid is a derivative of Rufanamide, an anti-epileptic medicament that is proposed to modulate voltage-gated sodium channels.
166196-11-8DTXSID70168080